
Nektar Therapeutics NKTR
€ 49.00
-1.36%
Geschäftsbericht 2023
hinzugefügt 05.03.2024
Nektar Therapeutics P/E 2011-2025 | NKTR
P/E Jährlich Nektar Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.606 | -0.706 | -3.89 | -7.92 | -8.06 | 10.7 | -133 | -10.7 | -22.3 | -34.5 | -9.99 | -5.68 | -5.38 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 10.7 | -133 | -17.8 |
P/E anderer Aktien in der Pharmaeinzelhändler
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AbCellera Biologics
ABCL
|
-5.28 | $ 3.56 | -2.47 % | $ 1.05 B | ||
|
AC Immune SA
ACIU
|
-4.18 | $ 2.81 | -2.43 % | $ 229 M | ||
|
ADiTx Therapeutics
ADTX
|
-0.00147 | $ 2.99 | 2.75 % | $ 39.4 K | ||
|
Aeterna Zentaris
AEZS
|
-4.94 | - | 5.93 % | $ 314 M | ||
|
Abeona Therapeutics
ABEO
|
-2.76 | $ 4.81 | -1.33 % | $ 103 M | ||
|
ARCA biopharma
ABIO
|
-5.78 | - | 1052.0 % | $ 415 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-1.71 | - | - | $ 26.5 M | ||
|
Akouos
AKUS
|
-1.98 | - | 0.23 % | $ 488 M | ||
|
Amneal Pharmaceuticals
AMRX
|
-24.7 | $ 11.96 | 0.17 % | $ 3.7 B | ||
|
Axcella Health
AXLA
|
-0.308 | - | -16.42 % | $ 249 M | ||
|
Acer Therapeutics
ACER
|
-0.463 | - | 2.71 % | $ 14 M | ||
|
Atreca
BCEL
|
-0.504 | - | -11.76 % | $ 5.79 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.544 | - | -2.5 % | $ 5.88 M | ||
|
argenx SE
ARGX
|
-33.7 | $ 898.63 | -1.89 % | $ 25 B | ||
|
Armata Pharmaceuticals
ARMP
|
-1.93 | $ 5.91 | 1.55 % | $ 213 M | ||
|
Achieve Life Sciences
ACHV
|
-3.03 | $ 4.68 | -2.2 % | $ 92.8 M | ||
|
BioDelivery Sciences International
BDSI
|
3.63 | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
-392 | - | 0.49 % | $ 251 B | ||
|
Acorda Therapeutics
ACOR
|
-0.0662 | - | -24.86 % | $ 820 K | ||
|
Ascendis Pharma A/S
ASND
|
-19.2 | $ 205.89 | -1.29 % | $ 5 B | ||
|
Alterity Therapeutics Limited
ATHE
|
-66.5 | $ 3.48 | 1.45 % | $ 8.37 B | ||
|
Acasti Pharma
ACST
|
-4.26 | - | 4.01 % | $ 150 M | ||
|
Bellerophon Therapeutics
BLPH
|
-3.96 | - | -74.18 % | $ 955 K | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-18 | - | -15.15 % | $ 60.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
55.7 | - | - | $ 40.3 B | ||
|
Baudax Bio
BXRX
|
-0.0133 | - | 0.59 % | $ 63 K | ||
|
AbbVie
ABBV
|
-15.6 K | $ 225.34 | -1.46 % | $ 399 B | ||
|
Cara Therapeutics
CARA
|
-0.457 | - | -3.03 % | $ 260 M | ||
|
CymaBay Therapeutics
CBAY
|
-32.5 | - | - | $ 3.45 B | ||
|
BioLineRx Ltd.
BLRX
|
-50 | $ 3.29 | 0.95 % | $ 908 M | ||
|
ChemoCentryx
CCXI
|
-0.0138 | - | - | $ 3.74 B | ||
|
Codiak BioSciences
CDAK
|
-6.45 | - | -55.98 % | $ 2.15 M | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
-7.39 | $ 15.35 | -12.11 % | $ 2.26 B | ||
|
Avid Bioservices
CDMO
|
-3.01 | - | - | $ 789 M | ||
|
Biogen
BIIB
|
11.9 | $ 182.33 | 0.19 % | $ 26.5 B | ||
|
Cerevel Therapeutics Holdings
CERE
|
-15.4 | - | - | $ 7.29 B | ||
|
ContraFect Corporation
CFRX
|
-0.0166 | - | -5.16 % | $ 5.39 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.57 | - | -1.52 % | $ 24.7 M | ||
|
Beam Therapeutics
BEAM
|
-6.64 | $ 27.55 | -4.72 % | $ 2.27 B | ||
|
BioMarin Pharmaceutical
BMRN
|
30.7 | $ 53.06 | -1.41 % | $ 10.1 B | ||
|
BioNTech SE
BNTX
|
6.11 | $ 96.0 | - | $ 27.2 B | ||
|
Clearside Biomedical
CLSD
|
-3.12 | - | - | $ 25.3 M | ||
|
Celsion Corporation
CLSN
|
-1.13 | - | -6.63 % | $ 13.9 M | ||
|
Clovis Oncology
CLVS
|
-0.873 | - | -7.23 % | $ 13 M | ||
|
Advaxis
ADXS
|
-0.0388 | - | -9.65 % | $ 45.9 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
-0.859 | - | - | $ 231 M | ||
|
Chimerix
CMRX
|
-1.26 | - | - | $ 756 M | ||
|
Concert Pharmaceuticals
CNCE
|
-1.29 | - | - | $ 401 M | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-10.2 | $ 9.36 | -2.65 % | $ 605 M | ||
|
AgeX Therapeutics
AGE
|
-0.00095 | - | -10.17 % | $ 12.2 K |